Thomas Strömberg

907 total citations
15 papers, 744 citations indexed

About

Thomas Strömberg is a scholar working on Molecular Biology, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Thomas Strömberg has authored 15 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Hematology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Thomas Strömberg's work include Growth Hormone and Insulin-like Growth Factors (7 papers), Multiple Myeloma Research and Treatments (7 papers) and Glycosylation and Glycoproteins Research (3 papers). Thomas Strömberg is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (7 papers), Multiple Myeloma Research and Treatments (7 papers) and Glycosylation and Glycoproteins Research (3 papers). Thomas Strömberg collaborates with scholars based in Sweden, Belgium and Egypt. Thomas Strömberg's co-authors include Helena Jernberg‐Wiklund, Kenneth Nilsson, Patrik Georgii‐Hemming, Olle Larsson, Anna Dimberg, Anders Österborg, Kristina Carlson, Leonard Girnita, Magnus Axelson and Eva Tiensuu Janson and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Oncotarget.

In The Last Decade

Thomas Strömberg

15 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Strömberg Sweden	12	503	214	206	168	151	15	744
Elena Tirrò Italy	19	423 0.8×	261 1.2×	265 1.3×	204 1.2×	207 1.4×	48	1.0k
Betty Gardie France	15	803 1.6×	194 0.9×	139 0.7×	121 0.7×	516 3.4×	36	1.3k
Ifat Geron United States	13	591 1.2×	117 0.5×	230 1.1×	186 1.1×	146 1.0×	25	1.0k
Shao-Qing Kuang United States	16	574 1.1×	235 1.1×	92 0.4×	46 0.3×	142 0.9×	17	1.1k
Michele Massimino Italy	22	496 1.0×	297 1.4×	316 1.5×	256 1.5×	249 1.6×	64	1.2k
Maria Stella Pennisi Italy	14	294 0.6×	187 0.9×	283 1.4×	190 1.1×	136 0.9×	34	798
Aizhen Xiao United States	15	393 0.8×	189 0.9×	49 0.2×	110 0.7×	253 1.7×	21	773
Jialiang Wang China	18	742 1.5×	211 1.0×	173 0.8×	23 0.1×	166 1.1×	29	950
Terry Lipari United States	5	419 0.8×	159 0.7×	135 0.7×	82 0.5×	69 0.5×	5	686
Javier Perales-Patón Spain	10	466 0.9×	91 0.4×	156 0.8×	73 0.4×	195 1.3×	18	752

Countries citing papers authored by Thomas Strömberg

Since Specialization

Citations

This map shows the geographic impact of Thomas Strömberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Strömberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Strömberg more than expected).

Fields of papers citing papers by Thomas Strömberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Strömberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Strömberg. The network helps show where Thomas Strömberg may publish in the future.

Co-authorship network of co-authors of Thomas Strömberg

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Strömberg. A scholar is included among the top collaborators of Thomas Strömberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Strömberg. Thomas Strömberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Strömberg, Thomas, Mattias Berglund, Yingbo Lin, et al.. (2015). Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells. Medical Oncology. 32(7). 188–188. 11 indexed citations

2.

Akopyan, Karen, Vendela Parrow, Thomas Strömberg, et al.. (2014). Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulin-like growth factor-1 receptor-independent mechanism. Oncotarget. 5(18). 8379–8392. 20 indexed citations

3.

Aleem, Eiman, et al.. (2011). Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: Clinical implications. International Journal of Oncology. 40(4). 1251–1258. 19 indexed citations

4.

Deng, Hua, Yingbo Lin, Daiana Vasilcanu, et al.. (2010). Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9. Biochemical and Biophysical Research Communications. 404(2). 667–671. 56 indexed citations

5.

Yin, Shengli, Ada Girnita, Thomas Strömberg, et al.. (2009). Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma. Neuro-Oncology. 12(1). 19–27. 80 indexed citations

6.

Strömberg, Thomas. (2005). IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Blood. 107(2). 669–678. 127 indexed citations

7.

Dimberg, Lina Y., Anna Dimberg, Thomas Strömberg, et al.. (2005). Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells. Blood. 106(4). 1346–1354. 22 indexed citations

8.

Menu, Eline, Helena Jernberg‐Wiklund, Thomas Strömberg, et al.. (2005). Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model. Blood. 107(2). 655–660. 107 indexed citations

9.

Strömberg, Thomas, Simon Ekman, Leonard Girnita, et al.. (2004). Targeting the Insulin-Like Growth Factor-I Receptor (IGF-IR) in Multiple Myeloma Cells Using Selective IGF-IR Tyrosine Kinase Inhibitors.. Blood. 104(11). 639–639. 1 indexed citations

10.

Vanderkerken, Karin, Eline Menu, Thomas Strömberg, et al.. (2004). Inhibiting the IGF-1 Receptor Tyrosine Kinase with Picropodophillin: An In Vitro and In Vivo Study in the 5T33MM Mouse Model.. Blood. 104(11). 640–640. 1 indexed citations

11.

Strömberg, Thomas, Anna Dimberg, Kristina Carlson, et al.. (2003). Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone. Blood. 103(8). 3138–3147. 133 indexed citations

12.

Strömberg, Thomas, et al.. (2002). Expression of the bcl‐2 family of pro‐ and anti‐apoptotic genes in multiple myeloma and normal plasma cells. European Journal Of Haematology. 69(2). 76–89. 81 indexed citations

13.

Ragnarsson, Lotten, et al.. (2001). Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells. Cancer Immunology Immunotherapy. 50(7). 382–390. 14 indexed citations

14.

Georgii‐Hemming, Patrik, Thomas Strömberg, Eva Tiensuu Janson, et al.. (1999). The Somatostatin Analog Octreotide Inhibits Growth of Interleukin-6 (IL-6)–Dependent and IL-6–Independent Human Multiple Myeloma Cell Lines. Blood. 93(5). 1724–1731. 35 indexed citations

15.

Georgii‐Hemming, Patrik, Thomas Strömberg, Eva Tiensuu Janson, et al.. (1999). The Somatostatin Analog Octreotide Inhibits Growth of Interleukin-6 (IL-6)–Dependent and IL-6–Independent Human Multiple Myeloma Cell Lines. Blood. 93(5). 1724–1731. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact